Get started
Author

Sophie Dawson

Observed names: S Dawson, S. Dawson
ORCID: 0000-0002-2903-3215
Observed ORCID: 0000-0002-2903-3215
OpenAlex ID: A5075256356
A machine-learning assisted review of the use of habit formation in medication adherence interventions for long-term conditions
2022 · L. Robinson, M. A. Arden, et al. · Health Psychology Review · 25
PDF
Real-World Adherence Among Adults With Cystic Fibrosis Is Low
2021 · Zhe Hui Hoo, Nikki Totton, et al. · CHEST Journal · 18
PDF
Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis
2023 · Sophie Dawson, Carla-Jane Girling, et al. · Cochrane Database of Systematic Reviews · 14
PDF
Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis
2021 · Amanda Bevan, Zhe Hui Hoo, et al. · Journal of Cystic Fibrosis · 8
“I think most people feel like healthcare professionals tell them to take their treatments and judge them for not taking them”: reflexive thematic analysis of the views of adults with cystic fibrosis on how treatment adherence is discussed in healthcare
2023 · Sophie Dawson, Karen Rodham, et al. · Psychology and Health · 4
Prospectively predicting Pseudomonas aeruginosa infection/s using routine data from the UK cystic fibrosis register
2021 · Nikki Totton, Mike Bradburn, et al. · Health Science Reports · 4
PDF
ePS5.05 Understanding objective adherence to preventative inhaled therapies at a centre level for quality improvement - a CFHealthHub (CFHH) improvement collaborative study
2019 · Z.H. Hoo, N. Totton, et al. · Journal of Cystic Fibrosis · 3
Optimising outcomes for adults with cystic fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework
2025 · Robert D. Sandler, Alan Anderson, et al. · Respiratory Medicine · 2
Corrigendum to “Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis” [J Cyst Fibros (2022), 21/2, 323-331]
2022 · Amanda Bevan, Zhe Hui Hoo, et al. · Journal of Cystic Fibrosis · 2
Factors associated with adherence to inhaled medicines in cystic fibrosis following the introduction of elexacaftor/tezacaftor/ivacaftor using electronically captured adherence data
2026 · Robert David Sandler, Lana Yin Hui Lai, et al. · Journal of Cystic Fibrosis · 1
Development of data processing algorithm to calculate adherence for adults with cystic fibrosis using inhaled therapy – a multi-center observational study within the CFHealthHub learning health system
2024 · Robert D Sandler, Lana Lai, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 1
P207 CFHealthHub allows clinicians to identify people with long nebuliser durations and intervene to reduce duration
2023 · R.D. Sandler, L. Lai, et al. · Journal of Cystic Fibrosis · 1
P220 The CFHealthHub Learning Health System - supporting a community of practice to deliver a normal life expectancy in cystic fibrosis
2023 · R.D. Sandler, S. Antrobus, et al. · Journal of Cystic Fibrosis · 1
PDF
P399 Using a digital learning health system to reduce medicines waste in cystic fibrosis – the Easy Medicines for Burden Reduction And Care Enhancement (EMBRACE) study
2023 · S. Cameron, S. Dawson, et al. · Journal of Cystic Fibrosis · 1
PDF
Future Discounting Bias and Scenarios Without Lock-Step FEV1/Life Expectancy Coherence May Result in Suboptimal Treatment Recommendations
2023 · Zhe Hui Hoo, Sophie Dawson, et al. · CHEST Journal · 1
PDF
Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis
2020 · Sophie Dawson, Lisa Cowap, et al. · Cochrane Database of Systematic Reviews · 1
PDF
Corrigendum to “Optimising outcomes for adults with Cystic Fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework” [Respirat. Med. 239 (2025)](S0954611125000575)(10.1016/j.rmed.2025.107995)
2025 · Robert D. Sandler, Alan Anderson, et al. · Newcastle University ePrints (Newcastle Univesity)
Corrigendum to “Optimising outcomes for adults with Cystic Fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework” [Respirat. Med. 239 (2025)]
2025 · Robert D. Sandler, Alan Anderson, et al. · Respiratory Medicine
PDF
Regarding the article entitled “Effect of elexacaftor/tezacaftor/ivacaftor on annual rate of lung function decline in people with cystic fibrosis”
2023 · Zhe Hui Hoo, Lana YH Lai, et al. · Journal of Cystic Fibrosis
PDF
P64 Using the CFHealthHub learning health system to understand the experiences of adults with cystic fibrosis of obtaining repeat supplies of nebulised medicines: results of a national survey
2022 · A Bevan, S Dawson, et al.
Corrigendum to "Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis" [J Cyst Fibros (2022), 21/2, 323-331, (J Cyst Fibros (2022), 21/2(323-331) (S1569199321014089), (10.1016/j.jcf.2021.09.007))
2022 · Amanda Bevan, Zhe Hui Hoo, et al. · Newcastle University ePrints (Newcastle Univesity)
Works count: 21
Citation count: 87
H-index: 4
I10-index: 3
Year
Topic
Type